Compounds that activate a sphingosine-1-phosphate receptor of the subtype 1 are provided. Certain compounds selectively activate the receptor subtype 1 in relation to the sphinogosine-1-phosphate receptor subtype 3. Uses and methods of inventive compounds for treatment of malconditions wherein activation, agonism, inhibition or antagonism of the S1P1 is medically indicated are provided.
提供了激活
鞘氨醇-1-
磷酸受体亚型1的化合物。某些化合物在与
鞘氨醇-1-
磷酸受体亚型3相比,选择性地激活受体亚型1。提供了使用和方法,用于治疗激活、激动、抑制或拮抗S1P1在医学上指示的疾病的创新化合物。